Using Fitbit and AI Chatbot to Support Exercise and Diabetes Management in Sedentary Adults with Type 2 Diabetes

What this Trial Is About

This research aims to evaluate the feasibility and acceptability of a 12-week program using Fitbit and AI-delivered diabetes self-management education and support DSMES with personalized text messages for adults with type 2 diabetes. The main goal is to find out if using a wearable fitness tracker combined with AI-tailored support can improve clinical outcomes for people with this condition. Participants in the intervention group will wear Fitbit devices daily and receive weekly personalized exercise goals and support messages from an AI Chatbot based on their activity levels. They can also interact with the AI Chatbot via text for additional education and goal setting. A control group will be identified through a review of medical records of patients who meet the study criteria but do not receive the intervention. Participants will have a baseline visit, wear the Fitbit and engage with the AI Chatbot for 12 weeks, and then complete a final visit. Researchers will measure feasibility aspects such as recruitment, retention, Fitbit use, response to messages, and technical issues. They will also assess participant satisfaction and changes in clinical measures like HbA1c, body mass index, blood pressure, lipid panel, weight, and diabetes distress during the 12-week period.

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D